These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29017154)

  • 1. Screening Performance of Placental Growth Factor for the Prediction of Low Birth Weight and Adverse Intrapartum and Neonatal Outcomes in a Term Low-Risk Population.
    Bligh LN; Greer RM; Kumar S
    Fetal Diagn Ther; 2018; 44(3):194-201. PubMed ID: 29017154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prelabor screening for intrapartum fetal compromise in low-risk pregnancies at term: cerebroplacental ratio and placental growth factor.
    Bligh LN; Alsolai AA; Greer RM; Kumar S
    Ultrasound Obstet Gynecol; 2018 Dec; 52(6):750-756. PubMed ID: 29227010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between maternal placental growth factor levels and intrapartum fetal compromise.
    Bligh LN; Greer RM; Kumar S
    Placenta; 2016 Dec; 48():63-67. PubMed ID: 27871474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review of maternal Placental Growth Factor levels in late pregnancy as a predictor of adverse intrapartum and perinatal outcomes.
    Sherrell H; Dunn L; Clifton V; Kumar S
    Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():26-34. PubMed ID: 29631209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in intrapartum maternal placental growth factor levels in pregnancies complicated by fetal compromise at term.
    Dunn L; Kumar S
    Placenta; 2018 Dec; 74():9-13. PubMed ID: 30594309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebroplacental ratio thresholds measured within 2 weeks before birth and risk of Cesarean section for intrapartum fetal compromise and adverse neonatal outcome.
    Bligh LN; Alsolai AA; Greer RM; Kumar S
    Ultrasound Obstet Gynecol; 2018 Sep; 52(3):340-346. PubMed ID: 28594099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biophysical and biochemical markers at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
    Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):194-202. PubMed ID: 26094952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A low fetal cerebroplacental ratio confers a greater risk of intrapartum fetal compromise and adverse neonatal outcomes in low risk multiparous women at term.
    Turner JM; Flatley C; Kumar S
    Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():15-21. PubMed ID: 30237135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Performance of Cerebroplacental Ratio Thresholds at Term for Prediction of Low Birthweight and Adverse Intrapartum and Neonatal Outcomes in a Term, Low-Risk Population.
    Bligh LN; Al Solai A; Greer RM; Kumar S
    Fetal Diagn Ther; 2018; 43(3):191-198. PubMed ID: 28746928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biophysical and biochemical markers at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
    Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):203-9. PubMed ID: 26224608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placental Growth Factor informed management of suspected pre-eclampsia or fetal growth restriction: The MAPPLE cohort study.
    Sharp A; Chappell LC; Dekker G; Pelletier S; Garnier Y; Zeren O; Hillerer KM; Fischer T; Seed PT; Turner M; Shennan AH; Alfirevic Z
    Pregnancy Hypertens; 2018 Oct; 14():228-233. PubMed ID: 29627351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting intrapartum fetal compromise at term using the cerebroplacental ratio and placental growth factor levels (PROMISE) study: randomised controlled trial protocol.
    Sherrell H; Clifton V; Kumar S
    BMJ Open; 2018 Aug; 8(8):e022567. PubMed ID: 30104317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in maternal placental growth factor levels during term labour.
    Dunn L; Flatley C; Kumar S
    Placenta; 2018 Jan; 61():11-16. PubMed ID: 29277266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An investigation of the effect of placental growth factor on intrapartum fetal compromise prediction in terminduced high risk pregnancies.
    Budak MŞ; Toprak G; Akgöl S; Obut M; Oglak C; Baglı I; Kahramanoglu I
    Ginekol Pol; 2018; 89(12):700-704. PubMed ID: 30618039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical evaluation of placental growth factor in routine practice in high-risk women presenting with suspected pre-eclampsia and/or fetal growth restriction.
    Ormesher L; Johnstone ED; Shawkat E; Dempsey A; Chmiel C; Ingram E; Higgins LE; Myers JE
    Pregnancy Hypertens; 2018 Oct; 14():234-239. PubMed ID: 29559205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. sFlt-1/PlGF and Doppler ultrasound parameters in SGA pregnancies with confirmed neonatal birth weight below 10th percentile.
    Kwiatkowski S; Bednarek-Jędrzejek M; Ksel J; Tousty P; Kwiatkowska E; Cymbaluk A; Rzepka R; Chudecka-Głaz A; Dołęgowska B; Torbè A
    Pregnancy Hypertens; 2018 Oct; 14():79-85. PubMed ID: 30527123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal Growth and Placental Growth Factor Umbilical Cord Blood Levels.
    Broere-Brown ZA; Schalekamp-Timmermans S; Jaddoe VWV; Steegers EAP
    Fetal Diagn Ther; 2018; 43(1):26-33. PubMed ID: 28926825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Performance of Placental Growth Factor in Women With Suspected Preeclampsia Attending Antenatal Facilities in Maputo, Mozambique.
    Ukah UV; Mbofana F; Rocha BM; Loquiha O; Mudenyanga C; Usta M; Urso M; Drebit S; Magee LA; von Dadelszen P
    Hypertension; 2017 Mar; 69(3):469-474. PubMed ID: 28137987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sFlt-1/PlGF ratio as a predictor for poor pregnancy and neonatal outcomes.
    Chang YS; Chen CN; Jeng SF; Su YN; Chen CY; Chou HC; Tsao PN; Hsieh WS
    Pediatr Neonatol; 2017 Dec; 58(6):529-533. PubMed ID: 28571908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of third-trimester combined screening model for prediction of adverse perinatal outcome.
    Miranda J; Triunfo S; Rodriguez-Lopez M; Sairanen M; Kouru H; Parra-Saavedra M; Crovetto F; Figueras F; Crispi F; Gratacós E
    Ultrasound Obstet Gynecol; 2017 Sep; 50(3):353-360. PubMed ID: 27706856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.